tiprankstipranks
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market
Holding VVOS?
Track your performance easily

Vivos Therapeutics (VVOS) Technical Analysis

154 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
3Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
3Neutral
5Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Vivos Therapeutics’s (VVOS) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Vivos Therapeutics is a Sell.
Vivos Therapeutics’s (VVOS) 20-Day exponential moving average is 2.41, while Vivos Therapeutics’s (VVOS) share price is $2.76, making it a Buy.
Vivos Therapeutics’s (VVOS) 50-Day exponential moving average is 2.55, while Vivos Therapeutics’s (VVOS) share price is $2.76, making it a Buy.

Vivos Therapeutics (VVOS) Pivot Points

Nov 20, 2024, 10:08 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.90
2.16
2.47
2.73
3.04
3.30
3.61
Fibonacci
2.16
2.37
2.51
2.73
2.94
3.08
3.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Vivos Therapeutics (VVOS) Moving Averages

Nov 20, 2024, 10:08 PM
Period
Simple
Exponential
MA5
2.56Buy
2.62Buy
MA10
2.45Buy
2.50Buy
MA20
2.34Buy
2.41Buy
MA50
2.29Buy
2.55Buy
MA100
3.12Sell
3.33Sell
MA200
5.50Sell
4.95Sell
Vivos Therapeutics’s (VVOS) 10-Day exponential moving average is 2.50, while Vivos Therapeutics’s (VVOS) share price is $2.76, making it a Buy.
Vivos Therapeutics’s (VVOS) 100-Day exponential moving average is 3.33, while Vivos Therapeutics’s (VVOS) share price is $2.76, making it a Sell.
Vivos Therapeutics’s (VVOS) stock price is $2.76 and Vivos Therapeutics’s (VVOS) 50-day simple moving average is 2.29, creating a Buy signal.
Vivos Therapeutics’s (VVOS) stock price is $2.76 and Vivos Therapeutics’s (VVOS) 100-day simple moving average is 3.12, creating a Sell signal.
Vivos Therapeutics’s (VVOS) stock price is $2.76 and Vivos Therapeutics’s (VVOS) 200-day simple moving average is 5.50, creating a Sell signal.

Vivos Therapeutics (VVOS) Technical Indicators

Nov 20, 2024, 10:08 PM
Name
Value
Implied Action
RSI (14)
65.12
Neutral
STOCH (9,6)
82.90
Sell
STOCHRSI (14)
85.44
Sell
MACD (12,26)
0.08
Sell
ADX (14)
22.19
Neutral
Williams %R
-17.63
Sell
CCI (14)
261.02
Sell
ATR (14)
0.23
-
Ultimate Oscillator
60.24
Neutral
ROC
26.01
Buy
Vivos Therapeutics’s (VVOS) Relative Strength Index (RSI) is 65.12, creating a Neutral signal.
Vivos Therapeutics’s (VVOS) Trend Strength Indicator (ADX) is 22.19, creating a Neutral signal.
Vivos Therapeutics’s (VVOS) Commodity Channel Index (CCI) is 261.02, creating a Sell signal.
Vivos Therapeutics’s (VVOS) Price Rate of Change (ROC) is 26.01, creating a Buy signal.

FAQ

Is VVOS a Buy, Hold, or Sell?
Based on VVOS’s technical indicators, VVOS is a Hold.
    What is VVOS’s RSI (14)?
    VVOS’s RSI (14) is 65.12, which suggests VVOS is a Neutral.
      What is VVOS’s MACD?
      VVOS’s MACD is 0.08, which suggests VVOS is a Sell.
        What is VVOS’s 5-day moving average?
        VVOS’s 5-day moving average is 2.56, which suggests VVOS is a Buy.
          What is VVOS’s 20-day moving average?
          VVOS 20-day moving average is 2.34, which suggests VVOS is a Buy.
            What is VVOS’s 50-day moving average?
            VVOS’s 50-day moving average is 2.29, which suggests VVOS is a Buy.
              What is VVOS’s 200-day moving average?
              VVOS’s 200-day moving average is 5.50, which suggests VVOS is a Sell.
                What is VVOS’s Williams % R (14)?
                VVOS’s Williams % R (14) is -17.63, which suggests VVOS is a Sell.
                  What is VVOS’s CCI (14)?
                  VVOS’s CCI (14) is 261.02, which suggests VVOS is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis